NCT04124887

Brief Summary

The aim of this study was to evaluate and compare the efficacy of NaF, NaF with TCP, NaF with CPP-ACP, and NaF with CXP varnishes on newly erupted first permanent molar teeth. The study was carried out in 40 healthy, high caries risk children (DMFS \>8), aged six to seven years with newly erupted permanent first molars who referred to the Pediatric Dentistry Clinic of Kırıkkale University Faculty of Dentistry, Kırıkkale, Turkey. A total of 140 teeth were divided randomly into four groups and the varnishes were applied to the determined teeth at baseline, one and three months. The same varnish was used, if there is more than one first molar to be applied of the same patient. The groups were comprised as follows: Group 1: Duraphat Varnish containing 5% NaF (Colgate-Palmolive, NSW, Australia) (n = 35), Group 2: Clinpro™ White Varnish containing 5% NaF with TCP (3M ESPE, MN, USA) (n = 35), Group 3: Embrace ™ Varnish containing 5% NaF with CXP (Pulpdent, MA, USA) (n = 35), Group 4: MI Varnish containing 5% NaF with CPP-ACP (GC, Tokyo, Japan) (n = 35). All dental treatments of the patients were completed before the varnish application and oral hygiene instructions were given to all children at the start of the study. Patients were called for follow up appointments at 1, 3 and 6 months, and in the follow-up period DIAGNOdent device (laser fluorescence scanning) was used to monitor mineralization changes. LF measurements were made at baseline (T0), after one month (T1) three months (T2) and six months (T3). Within and between group comparisons were analysed statistically.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 3, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2018

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2018

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

October 10, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 14, 2019

Completed
Last Updated

October 15, 2019

Status Verified

October 1, 2019

Enrollment Period

1 year

First QC Date

October 10, 2019

Last Update Submit

October 11, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Monitoring mineralization changes

    To monitor mineralization changes on permanent first molars, laser fluorescence scanning method was used with DiagnodentPen device.

    One, three, six months

Study Arms (4)

Sodium fluoride

ACTIVE COMPARATOR

Duraphat Varnish containing 5% Sodium fluoride

Drug: Sodium Fluoride

Tricalcium phosphate

EXPERIMENTAL

Clinpro™ White Varnish containing 5% NaF with TCP

Drug: Tricalcium Phosphate

Xylitol-coated calcium and phosphate

EXPERIMENTAL

Embrace ™ Varnish containing 5% NaF with CXP

Drug: Xylitol-coated calcium and phosphate

Casein phosphopeptide amorphous calcium phosphate

EXPERIMENTAL

MI Varnish containing 5% NaF with CPP-ACP

Drug: Casein phosphopeptide amorphous calcium phosphate

Interventions

Sodium Fluoride varnish was applied to the targeted teeth at baseline, one and three months.

Sodium fluoride

Varnish with Tricalcium Phosphate was applied to the targeted teeth at baseline, one and three months.

Tricalcium phosphate

Varnish with Xylitol-coated calcium and phosphate was applied to the targeted teeth at baseline, one and three months.

Xylitol-coated calcium and phosphate

Varnish with Casein phosphopeptide amorphous calcium phosphate was applied to the targeted teeth at baseline, one and three months.

Casein phosphopeptide amorphous calcium phosphate

Eligibility Criteria

Age6 Years - 7 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Subject has at least one fully erupted permanent first molar tooth

You may not qualify if:

  • Subject has a permanent first molar tooth with visible cavitation on the tooth surface Subject has a partially erupted permanent first molar tooth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırıkkale University

Kırıkkale, 71200, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Sodium Fluoridetricalcium phosphatePhosphatescasein phosphopeptide-amorphous calcium phosphate nanocomplex

Intervention Hierarchy (Ancestors)

FluoridesHydrofluoric AcidFluorine CompoundsInorganic ChemicalsSodium CompoundsCariostatic AgentsBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and AgriculturePhosphoric AcidsPhosphorus AcidsAcids, NoncarboxylicAcidsAnionsIonsElectrolytesPhosphorus Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asist prof

Study Record Dates

First Submitted

October 10, 2019

First Posted

October 14, 2019

Study Start

February 3, 2017

Primary Completion

February 8, 2018

Study Completion

February 15, 2018

Last Updated

October 15, 2019

Record last verified: 2019-10

Locations